Drug class
Diet Aids
"Diet Aids" is an informal, consumer-oriented category rather than a formal, standard therapeutic drug class recognized by regulatory bodies like the FDA. Read more about Diet Aids
66 drugs in this class 32 manufacturers
Drugs in Diet Aids
PHENTERMINE HCL
QSYMIA (phentermine HCl/topiramate)
PHENTERMINE HCL
PHENTERMINE HCL
PHENTERMINE HCL
SAXENDA (liraglutide)
BENZPHETAMINE HCL
LOMAIRA (phentermine HCl)
"Diet Aids" is an informal, consumer-oriented category rather than a formal, standard therapeutic drug class recognized by regulatory bodies like the FDA.
In medical practice and clinical pharmacology, these agents are formally classified as anti-obesity agents, anorexiants, or weight-loss medications.
They promote weight reduction through diverse mechanisms, including central nervous system appetite suppression, stimulation of satiety pathways via incretin mimetics, or inhibition of gastrointestinal fat absorption.
These products are primarily indicated for chronic weight management in clinical obesity or overweight associated with metabolic and cardiovascular comorbidities.
-
fda.gov
"Diet Aids" is an informal, consumer-oriented category rather than a formal, standard therapeutic drug class recognized by regulatory bodies like the FDA
-
polskieradio.pl
"Diet Aids" is an informal, consumer-oriented category rather than a formal, standard therapeutic drug class recognized by regulatory bodies like the FDA In medical practice and clinical pharmacology, these agents are formally classified as anti-obesity agents, anorexiants, or weight-loss medications They promote weight reduction through diverse mechanisms, including central nervous system appetite suppression, stimulation of satiety pathways via incretin mimetics, or inhibition of gastrointesti...
-
drugbank.com
In medical practice and clinical pharmacology, these agents are formally classified as anti-obesity agents, anorexiants, or weight-loss medications
-
drugs.com
In medical practice and clinical pharmacology, these agents are formally classified as anti-obesity agents, anorexiants, or weight-loss medications They promote weight reduction through diverse mechanisms, including central nervous system appetite suppression, stimulation of satiety pathways via incretin mimetics, or inhibition of gastrointestinal fat absorption These products are primarily indicated for chronic weight management in clinical obesity or overweight associated with metabolic and ca...
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.